Vaccine Preventable Diseases

Slides:



Advertisements
Similar presentations
The Evolving Adult Immunization Platform
Advertisements

2010 National Immunization Survey Report, Texas Child and Teen Vaccination Coverage Levels Jack Sims-Immunization Branch Manager Tony Aragon, MS-Epidemiologist.
Prevention of Ventilator Associated Pneumonia
Vaccines What is new ? Umayya M.Musharrafieh, MD American University of Beirut Medical Center November 10-12, 2006.
Implementing WA New State Exemption Requirements - Training for Schools and Child Cares/Preschools August XX, 2011 Preschool/Child Care Immunization Requirements.
Liza Chapman, Pharm.D. GPhA Annual Meeting
1 Cover page Let’s Review Changes in CDC Recommendations in 2011 Carolee’s Corner January 2012 MPCA
Importance of Vaccine Safety Decreases in disease risks and increased attention on vaccine risks Public confidence in vaccine safety is critical Low tolerance.
Communicable Diseases
Overcoming Disease in Your Community Gail Baker, RN Megan Davies, MD Gina Holland, RN Jenny Snow, MPH.
Pertussis Disease Pertussis (‘whooping cough’) is a bacterial infection affecting the respiratory system, caused by the organism Bordetella pertussis.
PROTECTING BABIES THROUGH IMMUNIZATION SAFE AND HEALTHY BABIES.
Disease surveillance is an epidemiological practice by which.
Implementing WA New State Exemption Requirements - Training for Schools and Child Cares/Preschools August XX, 2011 Preschool/Child Care Immunization Requirements.
Pertussis Kate Goheen March 25, 2009 Weill Cornell Medical College Class of 2010.
Vaccine Preventable Diseases in North Carolina: What’s Happening Elizabeth T. Draper RN Nurse Consultant NC Immunization Branch August 2009.
Case Study: Jennifer and James Amy B. Middleman, MD, MSEd, MPH Assistant Professor, Department of Pediatrics, Adolescent Medicine Section, Baylor College.
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
CHILDHOOD IMMUNIZATIONS
Child Care Provider Parents Siblings GrandparentsHealthcare Worker.
Developed By: Barbara (Bobbi) P. Clarke, PhD. RD Professor & Extension Health Specialist, Co-Director for The University of Tennessee Center for Community.
Infectious Disease Surveillance Section
North Carolina Immunization Program: Basics & Beyond.
ADULT IMMUNIZATIONS. RECOMMENDED ADULT VACCINES Tdap/Td—Tetanus, Diphtheria, Pertussis (every 10 years) HPV—Human Papillomavirus (3 doses years.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 68 Childhood Immunization.
Vaccines Tetanus Haemophilus MMR Nikki Hoheisel Morgan Rehm Michelle Savage Amy Lindgren.
Pertussis and Adolescents: It’s Time for a Boost A Slide Kit for School Nurses.
Better Health. No Hassles. Get Immunized! National Immunization Month.
Decreasing Incidence of Pertussis in Massachusetts Following the Introduction of Tdap Noelle Cocoros, Nancy Harrington, Rosa Hernandez, Jennifer Myers,
Dr. Zhen XU Branch of Respiratory Disease Prevention and Control Division for Disease Control and Emergency Response Chinese Center for Disease Control.
Common Childhood Infectious Diseases
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Rash Decisions: The Colorado Experience with “Maybe Measles” Emily Spence Davizon, Colorado Department of Public Health and Environment.
 >280 new cases  >38 children hospitalised  Epidemiological statistics - 1 expected case of death when case counts reach to 500  Every new case has.
Are You Up To Date? Recommendations For Adult Immunizations…
Thomas Clark, MD, MPH Centers for Disease Control and Prevention Immunization Program Managers Meeting November 16, 2010 Pertussis Epidemiology in the.
BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.
Vaccines Antibodies are produced by the body in response to the first attack by a germ or virus. Vaccine can trigger antibodies without being sick. You.
Troi Cunningham, RN Kentucky Immunization Program October 2015.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Measles Outbreak in Skopje, Republic of Macedonia, 2014 Erjona Shakjiri 1, D. Kochinski 1, Sh. Memeti 1, B. Aleksoski 1, K. Stavridis 1, V. Mikic 1, G.
New York City Department of Health and Mental Hygiene
Surveillance Update TISWG May, 2011 Rachel Wiseman, MPH Epidemiologist Emerging and Acute Infectious Diseases May 18, 2011.
What is a vaccine? A vaccine is a medicine that's given to help prevent a disease. Vaccines help the body produce antibodies. These antibodies protect.
Job Corps Webinar: Immunizations John Kulig MD MPH Lead Medical Specialist September 29 & 30, 2010.
Childhood Infectious Diseases Skimmia Japonica Rubella FAHAD AL ZAMIL Professor & Consultant Pediatric Infectious Diseases King Khalid University Hospital.
Mumps and Mumps Vaccine
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Childhood Immunization.
We teach our kids to share… But sometimes they share more than they should…
Characterization of a Large Mumps Outbreak Among Adolescents in Jerusalem, Israel in Communities Associated with Jewish Communities in New York.
Using Vaccine Preventable Disease Surveillance Indicators for Evaluation (of Reporting to CDC) Denise Woods-Stout Vaccine Preventable Disease Surveillance.
Jill Stauffer Field Epidemiologist – District 8 April 6, 2017
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
Quarantine and Isolation During the Sedgwick County
Overview of National Surveillance for Vaccine-Preventable Diseases
RISK R isk of Perinatal and Early Childhood Infection
Unit 4: Infection Control and Safety Precautions
Mumps Outbreak 2018.
Trudy V. Murphy, MD March 8, 2006 National Immunization Program
Haemophilus Influenzae
Childhood Infectious Diseases
Healthy People 2010 Focus Area 14
You Asked: Haemophilus and AFM
Varicella Vaccine Efficacy Estimates
National Immunization Conference
Mumps Vaccine Effectiveness During an Outbreak in New York City
Presentation transcript:

Vaccine Preventable Diseases Reporting Suspected Cases

Reportable Diseases Epidemiology Resource Center Surveillance and Investigation Contacts Reporting Fax Number: 317-234-2812 My Phone Number: 317-233-7112 My E-mail: kbuffin@isdh.in.gov Alternate Fax number: 317-233-7805 *Reportable Disease List (handout)

Karee Buffin. MS—Vaccine Preventable Disease Epidemiologist Epidemiology Resource Center Surveillance and Investigation Division Communicable Disease Responsibilities 2 N. Meridian Street, 5-K Indianapolis, IN 46204 Fax: 317-234-2812 Karee Buffin. MS—Vaccine Preventable Disease Epidemiologist 317-233-7112 kbuffin@isdh.in.gov Diphtheria Invasive Haemophilus influenzae Invasive Pneumococcal Disease Measles Mumps Pertussis (whooping cough) Polio Rubella Rubella, congenital syndrome Smallpox Tetanus Varicella/shingles (hospitalization or death and sentinel reporting) See Handout

ISDH Public Health Investigators Investigate the following: In accordance with the guidelines from the Communicable Disease Reporting Rule Measles, Mumps, Rubella, Pertussis, Diphtheria, Tetanus, Polio Varicella resulting in death or hospitalization Invasive Haemophilus Influenzae Invasive Pneumococcal Disease (cases less than or equal to 5 years of age) * The Rule is currently undergoing revisions

Communication “A trained immunization field representative of the department in cooperation with the local health officer” Contacting your immunization program’s public health investigators: Phone: see map (handout) E-mail Contacting the field staff supervisor: Sarah Murphy: 317-233-7603 smurphy@isdh.in.gov

Non-Sterile Sites Need not be reported Saliva Ear swabs Nasal swabs Wound swab, wound culture Eye Swab Fingernail or other infected external sites And other non-sterile sites need not be reported

Sterile Sites Fluids collected from these sites are expected to be sterile: Blood (venous or arterial cultures) CSF Pleural Fluid Peritoneal Fluid Pericardial Fluid Joint or Synovial Fluid Tympanocentesis

Haemophilus Influenzae (H.Flu) Bacterial Isolates are required to be sent for further evaluation. 1 type b in Indiana in 2007 How did this happen? Sensitivity reports needed for Drug Resistant patterns. When are these required to be reported?...

Reporting Requirement Immediately Web link to reporting rule: http://www.in.gov/isdh/publications/comm_dis_rule.pdf

Streptococcus Pneumoniae (Strep. Pneumo.) Bacterial Isolates are requested to be sent to ISDH lab for patients less than or equal to 5 years old. It is important to ask this of the lab as soon as you are aware of the case for serotyping. In 2007 ISDH lab has received 70% of the isolates for serotyping. Sensitivity reports needed for Drug Resistant patterns When are these cases required to be reported?...

Reporting Requirement 72 hours Web link to reporting rule: http://www.in.gov/isdh/publications/comm_dis_rule.pdf

Drug Resistant Patterns 30 Total isolates (Collected on patients less than 5 years old) 14 typed as 19A Not in the current pneumococcal vaccine for children Total Breakdown of 19A: 10/14 demonstrate Drug resistant Streptococcus Pneumoniae patterns 1/14 sensitive to antibiotics tested 3/14 Unknown patterns (not sent to ISDH labs)

Vaccine Preventable Disease Indiana Incidence 2006 Compared to Jan-June 2007 Year 2006 Jan-June 2007 Pertussis 280 26 Tetanus 2 Measles 1 Mumps 10 Rubella Haemophilus Influenzae 81 31 Streptococcus Pneumoniae 721 357

Vaccine Preventable Disease Indiana Incidence Jan-June 2006-07 Year Jan-June 2006 Jan-June 2007 Pertussis 105 26 Tetanus 1 Measles Mumps 10 Rubella Haemophilus Influenzae 35 31 Streptococcus Pneumoniae 354 357

Mumps Incidence in Indiana CDC clinical case definition: One counted in 2007 CDC clinical case definition: An illness with acute onset of unilateral or bilateral tender, self-limited swelling of the parotid or other salivary gland, lasting more than 2 days without other apparent cause.

Mumps Reporting Suspected Cases: Why not wait for the test results? Some results may take 3 weeks or more Other testing possibilities through the state lab One cannot rely solely on the accuracy of testing Time off of work, out of school Communicable Disease Reporting Rule: Indiana still recognizes the 9-day exclusion rule

Mumps News Proof of 2 MMRs does not guarantee 100% protection * Evidence of disease in patients who have received 2 doses of the mumps vaccine. 1997-1998 NY outbreak Iowa outbreak (recent) Efficacy *Source: VPD Surveillance Manual Chapter 7. Web Link: www.cdc.gov/vaccines/pubs/surv-manual/downloads/chpt07_mumps.pdf

Importance of Exclusion of Susceptibles: The Communicable Disease Reporting Rule for Indiana currently states: Exclude exposed susceptibles from school or the workplace from the12th to the 25th day after exposure to prevent the spread to other susceptibles. Example: Hospital nursery, (based on a fictional event).

Mumps Testing PCR Offered at ISDH labs: Buccal Swab (7days before – 9 days after parotid gland swelling) Detects the presence of DNA Generally offers quick results Culture also can be obtained from swab IgG, IgM (Offered at ISDH labs) Paired sera (Offered at ISDH labs) Clinical Picture: should be considered with testing results due to many false + IgM tests.

Consider other apparent causes: Oral surgery, ear surgery, surgery in general involving the jaw, ear, neck area. Hit by a: Ball bat to the jaw Baseball to the jaw Brother’s fist to the jaw Other objects to the jaw Other medical diagnosis consistent with parotitis.

Reporting Requirement? Within 72 hours Web link to reporting rule: http://www.in.gov/isdh/publications/comm_dis_rule.pdf

Reporting Requirement: IMMEDIATELY Pertussis Report a Suspected Case: Reporting Requirement: IMMEDIATELY Problems: Consequences for waiting for lab testing and late reporting. Share case review with Mom’s comments: Encouragement from a parent. (Smiley is HIPPA compliant) Reporting: relying on labs to report

Pertussis Testing Issues Recommended testing: Culture and DFA: available at ISDH labs PCR: currently unavailable at ISDH lab Serology is not recommended for pertussis diagnosis. Clinical picture is more valuable than the serology results.

Indiana Reported Pertussis Cases 2002 - 2006

Tdap, Tdap, Tdap ACIP Tdap Recommendations http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a1.htm One dose of Tdap should be used to replace a Td booster dose in adults and children of recommended age (includes wound management). (Note: Two manufactures with different recommendations.)

Varicella Reporting: Outbreaks Definition: greater than or equal to 5 cases in a place in children less than 13 years old within one incubation period. Also: greater than or equal to 3 cases related in place in persons greater that or equal to 13 years of age within one incubation period.

Varicella Reporting: Outbreaks including ‘breakthrough’ disease One incubation Period: 21 days A lot can happen in 21 days: Example: School Jan 30, 5 cases By Feb 20, 31 cases * Recommend 2 doses varicella vaccine for outbreak management and current ACIP.

Current ACIP Recommendations Routine vaccination at 12-15 months 2nd dose recommended at 4-6 years of age; 3 months as minimum interval between doses 2nd dose recommended for person of ANY age who has had only 1 dose 13 yrs or older, if not immune-2 doses at least 4 weeks apart. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm Current Web address

ACIP Recommendations and Vaccine Administration Current Issues: State funding does not always match the recommendations. Publicly funded vaccine programs should check the policy prior to administration. Outbreak conditions: Communicate needs with the Immunization Program. Vaccine needed, expected numbers Initiate an outbreak response.

Varicella Sentinel Reporting Since 2004 Breakthrough disease may decrease with second dose of varicella introduced. Incidence of severe varicella with 2 doses of varicella in Indiana is zero, (using sentinel surveillance data).

Acknowledgements Wayne Staggs Dr. Charlene Graves Immunization Program Special recognition to the Immunization Field Staff Pam Pontones Kristin Ryker